Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids
Liver is the primary acting site of insulin. In this study, we developed innovative nanoparticles for oral and liver-targeted delivery of insulin by using enterohepatic circulation of bile acids. The nanoparticles were produced from cholic acid and quaternary ammonium modified chitosan derivative an...
Main Authors: | Zhe Zhang, Hongxiang Li, Guangrui Xu, Ping Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2018.1469685 |
Similar Items
-
Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat
by: Maral Mahboubi Kancha, et al.
Published: (2024-01-01) -
Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery
by: Robin Durník, et al.
Published: (2022-05-01) -
A comprehensive review of oral chitosan drug delivery systems: Applications for oral insulin delivery
by: Alfatama Mulham, et al.
Published: (2024-02-01) -
HPMCP-Coated Microcapsules Containing the Ctx(Ile<sup>21</sup>)-Ha Antimicrobial Peptide Reduce the Mortality Rate Caused by Resistant <i>Salmonella</i> Enteritidis in Laying Hens
by: Cesar Augusto Roque-Borda, et al.
Published: (2021-05-01) -
Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery
by: Salma Seyam, et al.
Published: (2020-10-01)